Items where authors include "Dafni, U."

Article

Peters, S., Letovanec, I., Mauer, M. et al. (15 more authors) (2023) Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. Lung Cancer, 175. pp. 141-151. ISSN 0169-5002

Peters, S., Danson, S. orcid.org/0000-0002-3593-2890, Ejedepang, D. et al. (19 more authors) (2021) Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. Lung Cancer, 161. pp. 76-85. ISSN 0169-5002

Peters, S., Danson, S. orcid.org/0000-0002-3593-2890, Hasan, B. et al. (35 more authors) (2020) A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial. Journal of Thoracic Oncology, 15 (10). pp. 1647-1656. ISSN 1556-0864